Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent metabolic disorder characterized by substantial clinical heterogeneity and frequent association with obesity, insulin resistance, type 2 diabetes mellitus, dyslipidemia, visceral adiposity, and alterations in body composition. This s...
Cristian Arturo Abia-Meashima, Gil Alejandro Garrido Echeverria, María Cristina Martínez Mazón et al.· IECCMEXICO· 0 citations
Pharmacogenomic information showed potential utility for medication selection, dose modification, drug avoidance, risk stratification, and prevention of recurrent adverse events, although its clinical value depends on integration with renal and hepatic function, comorbidities, drug interactions, disease severity, and c...
Dayanna Estefania Fernández Astudillo, Cristian David Castro Hernandez, María Alejandra Galindo Van Strahlen et al.· International science journa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.